Chemiluminescence Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,995	250 Pages	Fairfield Market Research	December, 2023	FCSL18382084

Best Price Guarantee
Price	from $4,995
Length	250 Pages
Publisher	Fairfield Market Research
Published Date	December, 2023
SKU	FCSL18382084

Chemiluminescence Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global Chemiluminescence Immunoassay market, which achieved a valuation of US$ 8.9 billion in 2024. By 2031, the market is expected to reach a valuation of US$ 21 billion, with the highest revenue generated through Chemiluminescence Immunoassay Consumables during the same period.

Chemiluminescence immunoassay solutions play a crucial role in diagnosing chronic health conditions such as autoimmune disorders, infectious diseases, diabetes, cardiovascular diseases, obesity, and cancer. They are also utilized in pharmaceutical manufacturing and research centers for therapeutic medication monitoring.

Recent advancements in diagnostic technology have led to significant progress in the identification of antibodies, making chemiluminescence immunoassay more automated and akin to clinical chemistry laboratories. The demand for these tests is expected to grow due to technical improvements in disease detection, increased need for preventive diagnosis, and treatment monitoring.

The proliferation of high-throughput laboratories is being witnessed as large-scale laboratories use aggressive scheduling technology to capitalize on their service and quality capabilities, outpacing small and medium-sized laboratories. Moreover, major medical laboratories worldwide are expanding their businesses through mergers and acquisitions, leading to an increase in laboratory tests and volume, which, in turn, drives the adoption of automation and integration, contributing to market growth.

Key Growth Drivers
1. Advancements in Diagnostic Technology: Ongoing advancements in diagnostic technology, especially in antibody identification, are expected to drive the growth of chemiluminescence immunoassay procedures.
2. Increasing Demand for High-Throughput Facilities: The demand for high-throughput facilities is growing as these laboratories can handle larger volumes efficiently.
3. Mergers and Acquisitions: Major medical laboratories are expanding through mergers and acquisitions, increasing the adoption of automation and integration, thereby propelling market growth.

Opportunities by Region

Asia Pacific is expected to experience the fastest growth in the Chemiluminescence Immunoassay market during the forecast period. Growing awareness of chronic diseases in emerging economies like China and India, coupled with the approval and introduction of novel chemiluminescence immunoassay analyzer systems by local companies, is driving regional market expansion.

In North America, the market is expected to witness significant growth due to acquisitions made by key market players. Companies like PerkinElmer, Inc. are focusing on expanding their commercial diagnostics business through acquisitions and incorporating new chemiluminescence products in various areas of diagnostics.

Competitive Landscape

The Chemiluminescence Immunoassay market is moderately competitive, with key players including DiaSorin S.p.A., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Immunodiagnostic Systems, Siemens Healthineers, Beckman Coulter Inc., F. Hoffmann-La Roche AG, Inova Diagnostics, Inc., Maccura Biotechnology Co., Ltd., and Ortho Clinical Diagnostics.

Market Segmentation Covered in Chemiluminescence Immunoassay Industry Analysis

By Product Type
• Instruments
Automated
Semi-automated
• Consumables
• Software & Services

By Application
• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease
• Autoimmune Disease
• Other Applications

By End-use
• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Other End-uses

By Region
• North America
• Europe
• APAC
• Latin America
• MEA

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.

1. Executive Summary: 1.1. Global Chemiluminescence Immunoassay Market Snapshot; 1.2. Future Projections; 1.3. Key Market Trends; 1.4. Regional Snapshot, by Value, 2023; 1.5. Analyst Recommendations
2. Market Overview: 2.1. Market Definitions and Segmentations; 2.2. Market Dynamics; 2.2.1. Drivers; 2.2.2. Restraints; 2.2.3. Market Opportunities; 2.3. Value Chain Analysis; 2.4. Porter’s Five Forces Analysis; 2.5. Covid-19 Impact Analysis; 2.5.1. Supply; 2.5.2. Demand; 2.6. Impact of Ukraine-Russia Conflict; 2.7. Economic Overview; 2.7.1. World Economic Projections; 2.8. Pestle Analysis
3. Global Chemiluminescence Immunoassay Market Outlook, 2018 – 2031: 3.1. Global Chemiluminescence Immunoassay Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031; 3.1.1. Key Highlights; 3.1.1.1. Instruments; 3.1.1.2. Automated; 3.1.1.3. Semi-automated; 3.1.1.4. Consumables; 3.1.1.5. Software & Services; 3.2. Global Chemiluminescence Immunoassay Market Outlook, by Application, Value (US$ Bn), 2018 – 2031; 3.2.1. Key Highlights; 3.2.1.1. Therapeutic Drug Monitoring; 3.2.1.2. Oncology; 3.2.1.3. Cardiology; 3.2.1.4. Endocrinology; 3.2.1.5. Infectious Disease; 3.2.1.6. Autoimmune Disease; 3.2.1.7. Other Applications; 3.3. Global Chemiluminescence Immunoassay Market Outlook, by End Use, Value (US$ Bn), 2018 – 2031; 3.3.1. Key Highlights; 3.3.1.1. Hospitals; 3.3.1.2. Clinical Laboratories; 3.3.1.3. Pharmaceutical & Biotechnology Companies; 3.3.1.4. Other End-uses; 3.4. Global Chemiluminescence Immunoassay Market Outlook, by Region, Value (US$ Bn), 2018 – 2031; 3.4.1. Key Highlights; 3.4.1.1. North America; 3.4.1.2. Europe; 3.4.1.3. Asia Pacific; 3.4.1.4. Latin America; 3.4.1.5. Middle East & Africa
4. North America Chemiluminescence Immunoassay Market Outlook, 2018 – 2031: 4.1. North America Chemiluminescence Immunoassay Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031; 4.1.1. Key Highlights; 4.1.1.1. Instruments; 4.1.1.2. Automated; 4.1.1.3. Semi-automated; 4.1.1.4. Consumables; 4.1.1.5. Software & Services; 4.2. North America Chemiluminescence Immunoassay Market Outlook, by Application, Value (US$ Bn), 2018 – 2031; 4.2.1. Key Highlights; 4.2.1.1. Therapeutic Drug Monitoring; 4.2.1.2. Oncology; 4.2.1.3. Cardiology; 4.2.1.4. Endocrinology; 4.2.1.5. Infectious Disease; 4.2.1.6. Autoimmune Disease; 4.2.1.7. Other Applications; 4.3. North America Chemiluminescence Immunoassay Market Outlook, by End Use, Value (US$ Bn), 2018 – 2031; 4.3.1. Key Highlights; 4.3.1.1. Hospitals; 4.3.1.2. Clinical Laboratories; 4.3.1.3. Pharmaceutical & Biotechnology Companies; 4.3.1.4. Other End-uses; 4.3.2. Bps Analysis/Market Attractiveness Analysis; 4.4. North America Chemiluminescence Immunoassay Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 4.4.1. Key Highlights; 4.4.1.1. U.S. Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 4.4.1.2. U.S. Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 4.4.1.3. U.S. Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 4.4.1.4. Canada Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 4.4.1.5. Canada Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 4.4.1.6. Canada Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 4.4.2. Bps Analysis/Market Attractiveness Analysis
5. Europe Chemiluminescence Immunoassay Market Outlook, 2018 – 2031: 5.1. Europe Chemiluminescence Immunoassay Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031; 5.1.1. Key Highlights; 5.1.1.1. Instruments; 5.1.1.2. Automated; 5.1.1.3. Semi-automated; 5.1.1.4. Consumables; 5.1.1.5. Software & Services; 5.2. Europe Chemiluminescence Immunoassay Market Outlook, by Application, Value (US$ Bn), 2018 – 2031; 5.2.1. Key Highlights; 5.2.1.1. Therapeutic Drug Monitoring; 5.2.1.2. Oncology; 5.2.1.3. Cardiology; 5.2.1.4. Endocrinology; 5.2.1.5. Infectious Disease; 5.2.1.6. Autoimmune Disease; 5.2.1.7. Other Applications; 5.3. Europe Chemiluminescence Immunoassay Market Outlook, by End Use, Value (US$ Bn), 2018 – 2031; 5.3.1. Key Highlights; 5.3.1.1. Hospitals; 5.3.1.2. Clinical Laboratories; 5.3.1.3. Pharmaceutical & Biotechnology Companies; 5.3.1.4. Other End-uses; 5.3.2. Bps Analysis/Market Attractiveness Analysis; 5.4. Europe Chemiluminescence Immunoassay Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 5.4.1. Key Highlights; 5.4.1.1. Germany Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 5.4.1.2. Germany Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 5.4.1.3. Germany Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 5.4.1.4. U.K. Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 5.4.1.5. U.K. Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 5.4.1.6. U.K. Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 5.4.1.7. France Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 5.4.1.8. France Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 5.4.1.9. France Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 5.4.1.10. Italy Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 5.4.1.11. Italy Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 5.4.1.12. Italy Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 5.4.1.13. Turkey Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 5.4.1.14. Turkey Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 5.4.1.15. Turkey Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 5.4.1.16. Russia Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 5.4.1.17. Russia Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 5.4.1.18. Russia Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 5.4.1.19. Rest Of Europe Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 5.4.1.20. Rest Of Europe Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 5.4.1.21. Rest Of Europe Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 5.4.2. Bps Analysis/Market Attractiveness Analysis
6. Asia Pacific Chemiluminescence Immunoassay Market Outlook, 2018 – 2031: 6.1. Asia Pacific Chemiluminescence Immunoassay Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031; 6.1.1. Key Highlights; 6.1.1.1. Instruments; 6.1.1.2. Automated; 6.1.1.3. Semi-automated; 6.1.1.4. Consumables; 6.1.1.5. Software & Services; 6.2. Asia Pacific Chemiluminescence Immunoassay Market Outlook, by Application, Value (US$ Bn), 2018 – 2031; 6.2.1. Key Highlights; 6.2.1.1. Therapeutic Drug Monitoring; 6.2.1.2. Oncology; 6.2.1.3. Cardiology; 6.2.1.4. Endocrinology; 6.2.1.5. Infectious Disease; 6.2.1.6. Autoimmune Disease; 6.2.1.7. Other Applications; 6.3. Asia Pacific Chemiluminescence Immunoassay Market Outlook, by End Use, Value (US$ Bn), 2018 – 2031; 6.3.1. Key Highlights; 6.3.1.1. Hospitals; 6.3.1.2. Clinical Laboratories; 6.3.1.3. Pharmaceutical & Biotechnology Companies; 6.3.1.4. Other End-uses; 6.3.2. Bps Analysis/Market Attractiveness Analysis; 6.4. Asia Pacific Chemiluminescence Immunoassay Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 6.4.1. Key Highlights; 6.4.1.1. China Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 6.4.1.2. China Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 6.4.1.3. China Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 6.4.1.4. Japan Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 6.4.1.5. Japan Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 6.4.1.6. Japan Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 6.4.1.7. South Korea Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 6.4.1.8. South Korea Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 6.4.1.9. South Korea Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 6.4.1.10. India Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 6.4.1.11. India Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 6.4.1.12. India Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 6.4.1.13. Southeast Asia Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 6.4.1.14. Southeast Asia Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 6.4.1.15. Southeast Asia Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 6.4.1.16. Rest Of Asia Pacific Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 6.4.1.17. Rest Of Asia Pacific Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 6.4.1.18. Rest Of Asia Pacific Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 6.4.2. Bps Analysis/Market Attractiveness Analysis
7. Latin America Chemiluminescence Immunoassay Market Outlook, 2018 – 2031: 7.1. Latin America Chemiluminescence Immunoassay Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031; 7.1.1. Key Highlights; 7.1.1.1. Instruments; 7.1.1.2. Automated; 7.1.1.3. Semi-automated; 7.1.1.4. Consumables; 7.1.1.5. Software & Services; 7.2. Latin America Chemiluminescence Immunoassay Market Outlook, by Application, Value (US$ Bn), 2018 – 2031; 7.2.1. Key Highlights; 7.2.1.1. Therapeutic Drug Monitoring; 7.2.1.2. Oncology; 7.2.1.3. Cardiology; 7.2.1.4. Endocrinology; 7.2.1.5. Infectious Disease; 7.2.1.6. Autoimmune Disease; 7.2.1.7. Other Applications; 7.3. Latin America Chemiluminescence Immunoassay Market Outlook, by End Use, Value (US$ Bn), 2018 – 2031; 7.3.1. Key Highlights; 7.3.1.1. Hospitals; 7.3.1.2. Clinical Laboratories; 7.3.1.3. Pharmaceutical & Biotechnology Companies; 7.3.1.4. Other End-uses; 7.3.2. Bps Analysis/Market Attractiveness Analysis; 7.4. Latin America Chemiluminescence Immunoassay Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 7.4.1. Key Highlights; 7.4.1.1. Brazil Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 7.4.1.2. Brazil Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 7.4.1.3. Brazil Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 7.4.1.4. Mexico Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 7.4.1.5. Mexico Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 7.4.1.6. Mexico Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 7.4.1.7. Argentina Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 7.4.1.8. Argentina Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 7.4.1.9. Argentina Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 7.4.1.10. Rest Of Latin America Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 7.4.1.11. Rest Of Latin America Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 7.4.1.12. Rest Of Latin America Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 7.4.2. Bps Analysis/Market Attractiveness Analysis
8. Middle East & Africa Chemiluminescence Immunoassay Market Outlook, 2018 – 2031: 8.1. Middle East & Africa Chemiluminescence Immunoassay Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031; 8.1.1. Key Highlights; 8.1.1.1. Instruments; 8.1.1.2. Automated; 8.1.1.3. Semi-automated; 8.1.1.4. Consumables; 8.1.1.5. Software & Services; 8.2. Middle East & Africa Chemiluminescence Immunoassay Market Outlook, by Application, Value (US$ Bn), 2018 – 2031; 8.2.1. Key Highlights; 8.2.1.1. Therapeutic Drug Monitoring; 8.2.1.2. Oncology; 8.2.1.3. Cardiology; 8.2.1.4. Endocrinology; 8.2.1.5. Infectious Disease; 8.2.1.6. Autoimmune Disease; 8.2.1.7. Other Applications; 8.3. Middle East & Africa Chemiluminescence Immunoassay Market Outlook, by End Use, Value (US$ Bn), 2018 – 2031; 8.3.1. Key Highlights; 8.3.1.1. Hospitals; 8.3.1.2. Clinical Laboratories; 8.3.1.3. Pharmaceutical & Biotechnology Companies; 8.3.1.4. Other End-uses; 8.3.2. Bps Analysis/Market Attractiveness Analysis; 8.4. Middle East & Africa Chemiluminescence Immunoassay Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 8.4.1. Key Highlights; 8.4.1.1. GCC Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 8.4.1.2. GCC Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 8.4.1.3. GCC Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 8.4.1.4. South Africa Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 8.4.1.5. South Africa Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 8.4.1.6. South Africa Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 8.4.1.7. Egypt Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 8.4.1.8. Egypt Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 8.4.1.9. Egypt Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 8.4.1.10. Nigeria Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 8.4.1.11. Nigeria Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 8.4.1.12. Nigeria Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 8.4.1.13. Rest Of Middle East & Africa Chemiluminescence Immunoassay Market by Product Type, Value (US$ Bn), 2018 – 2031; 8.4.1.14. Rest Of Middle East & Africa Chemiluminescence Immunoassay Market by Application, Value (US$ Bn), 2018 – 2031; 8.4.1.15. Rest Of Middle East & Africa Chemiluminescence Immunoassay Market by End Use, Value (US$ Bn), 2018 – 2031; 8.4.2. Bps Analysis/Market Attractiveness Analysis
9. Competitive Landscape: 9.1. By End Use Vs by Application Heat Map; 9.2. Manufacturer Vs by Application Heatmap; 9.3. Company Market Share Analysis, 2023; 9.4. Competitive Dashboard; 9.5. Company Profiles; 9.5.1. DiaSorin S.p.a.; 9.5.1.1. Company Overview; 9.5.1.2. Product Type Portfolio; 9.5.1.3. Financial Overview; 9.5.1.4. Business Strategies and Development; 9.5.2. Abbott Laboratories; 9.5.2.1. Company Overview; 9.5.2.2. Product Type Portfolio; 9.5.2.3. Financial Overview; 9.5.2.4. Business Strategies and Development; 9.5.3. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; 9.5.3.1. Company Overview; 9.5.3.2. Product Type Portfolio; 9.5.3.3. Financial Overview; 9.5.3.4. Business Strategies and Development; 9.5.4. Immunodiagnostic Systems; 9.5.4.1. Company Overview; 9.5.4.2. Product Type Portfolio; 9.5.4.3. Financial Overview; 9.5.4.4. Business Strategies and Development; 9.5.5. Siemens Healthineers; 9.5.5.1. Company Overview; 9.5.5.2. Product Type Portfolio; 9.5.5.3. Financial Overview; 9.5.5.4. Business Strategies and Development; 9.5.6. Beckman Coulter Inc.; 9.5.6.1. Company Overview; 9.5.6.2. Product Type Portfolio; 9.5.6.3. Financial Overview; 9.5.6.4. Business Strategies and Development; 9.5.7. F. Hoffmann-La Roche AG; 9.5.7.1. Company Overview; 9.5.7.2. Product Type Portfolio; 9.5.7.3. Financial Overview; 9.5.7.4. Business Strategies and Development; 9.5.8. Inova Diagnostics, Inc.; 9.5.8.1. Company Overview; 9.5.8.2. Product Type Portfolio; 9.5.8.3. Financial Overview; 9.5.8.4. Business Strategies and Development; 9.5.9. Maccura Biotechnology Co., Ltd.; 9.5.9.1. Company Overview; 9.5.9.2. Product Type Portfolio; 9.5.9.3. Financial Overview; 9.5.9.4. Business Strategies and Development; 9.5.10. Ortho Clinical Diagnostics; 9.5.10.1. Company Overview; 9.5.10.2. Product Type Portfolio; 9.5.10.3. Financial Overview; 9.5.10.4. Business Strategies and Development
10. Appendix: 10.1. Research Methodology; 10.2. Report Assumptions; 10.3. Acronyms And Abbreviations

Research Assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Chemiluminescence Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Chemiluminescence Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Lipopolysaccharides Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Immunoassay Interference Blocker Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Multiplex Detection Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Molecular Grade Plates Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Food Grade Phosphate Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Food Grade Cellulose Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Research Assistance

Other tasks